Innovation of Liposomal Carriers
What we do?
Nanologistics develops and manufactures liposomal molecular carriers for companies in the dietary supplement, cosmetic, and pharmaceutical sectors.
Liposomal carriers (liposomes) enhance the absorption of active molecules and protect them from external environmental factors.
Our company has developed the first functional and commercially available multi-component liposomes. These allow for multiple active molecules to be encapsulated within a single liposomal vesicle.
Compared to other products on the market, Nanologistics liposomes are characterized by smaller particle size and lower polydispersity, resulting in significantly improved absorption.
The company has successfully secured the InoStartas project, receiving 280,100 EUR in state funding for product development.
We are currently seeking business development partners who can contribute to the company’s growth and expansion.
The company has successfully secured the InoStartas project, receiving 280,100 EUR in state funding for product development.
We are currently seeking business development partners who can contribute to the company’s growth and expansion.
Who we are?
A Lithuanian biotechnology company developing innovative liposomal carriers for the dietary supplement, cosmetic, and pharmaceutical markets.
The company’s vision originated in 2020 and was officially established in February 2023. Founded by three colleagues, the company is growing through a combination of personal investment and the EU-funded project, “InoStartas.”
Who we are?
A Lithuanian biotechnology company developing innovative liposomal carriers for the dietary supplement, cosmetic, and pharmaceutical markets.
The company’s vision originated in 2020 and was officially established in February 2023. Founded by three colleagues, the company is growing through a combination of personal investment and the EU-funded project, “InoStartas.”
Our Core Principles
Scientific thinking
Data-driven decisions
Passion for Excellence
Collaborative Relationships
Respect
Products and services
For the pharmaceutical industry
- Contract research services (CRO) specializing in liposomal structures.
- Vit. D3, K2 (100 and 100 µg/ml)
- Vit. D3 (15 µg/ml)
- Vit. D3, K2, E (100 µg/ml, 100 µg/ml, 1 mg/ml)
- Vit. E (1.3 mg/ml)
- Product portfolio currently under development
Partnerships
We are proud of our strong partnership with Vytautas Magnus University, specifically the laboratory of Professor Saulius Šatkauskas and the VMU Communication and Technology Transfer Center (KTPC).
Saulius Šatkauskas and his colleagues Salvijus Vykertas and Dr. Baltramiejus Jakštys contribute significantly to the project’s success.
VMU KTPC department contributes to responsible project management and preparation of new projects.
We are currently seeking investors committed to contributing to the company’s development and growth. Our goal is to find a partner who believes in liposomal technology and shares the core values of our team.
We are currently seeking investors committed to contributing to the company’s development and growth. Our goal is to find a partner who believes in liposomal technology and shares the core values of our team.
Andrius Kočevas
CEO
10 years in biotech, business & product management, leading high competence and performance teams
Edvinas Grauželis
CCO
10 years in food supplement biotech sales, business development, and team management. Certified coach.
Eventas Šaučiūnas
CTO
10 years in industrial-scale product and tech dev, QA, and R&D project management.
Company Details:
Nanologistics, UAB
Reg. No. 306247366
Adress: Žaibo g. 1C-2, Noreikiškių k., Kauno r.